SCHEMBL6180584

SCHEMBL6180584

O=S(=O)(c1ccccc1)N1CCCC1c1ccccc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 1/20 0.74
PSEN2 P49810 1/20 0.74
APH1B Q8WW43 1/20 0.74
NCSTN Q92542 1/20 0.74
APH1A Q96BI3 1/20 0.74
PSENEN Q9NZ42 1/20 0.74
CYP3A4 P08684 2/20 0.68
CYP2C19 P33261 2/20 0.68
TRPA1 O75762 3/20 0.68
LMNA P02545 1/20 0.65
ALDH1A1 P00352 3/20 0.65
RAB9A P51151 1/20 0.65
KMT2A Q03164 1/20 0.65
CYP1A2 P05177 1/20 0.58
CYP2C9 P11712 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
LOXL2 Q9Y4K0 2/20 0.57
USP2 O75604 1/20 0.53
ACLY P53396 1/20 0.52
CHRNB2 P17787 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6180588 1.00 PSEN1 (0.74) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6175853 0.90 PSEN1 (0.92) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6180423 0.90 TRPA1 (0.86) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6180426 0.90 TRPA1 (0.86) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6175850 0.90 PSEN1 (0.92) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6177618 0.90 PSEN1 (0.69) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6177624 0.90 PSEN1 (0.69) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6176840 0.90 PSEN1 (0.82) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6176835 0.90 PSEN1 (0.82) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6177802 0.87 TRPA1 (0.64) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165510-B1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS HOFFMANN LA ROCHE (CH) 2005-09-28 EP disclosed
EP-1165510-A1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2002-01-02 EP disclosed
US-6284785-B1 HAVING ACTIVITY AS LIGANDS OF METABOTROPIC GLUTAMATE RECEPTORS HOFFMANN- LA ROCHE INC. 2001-09-04 US disclosed
WO-2000058285-A1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2000-10-05 WO disclosed